|
J. Biol. Chem., Vol. 263, Issue 16, 7581-7590, 06, 1988
Regulation of epidermal growth factor-stimulated formation of inositol phosphates in A-431 cells by calcium and protein kinase C
M Wahl and G Carpenter
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
Epidermal growth factor (EGF) treatment of A-431 cells induces a biphasic
increase in the levels of inositol phosphates. The growth factor produces
an initial, rapid increase in the level of inositol 1,4,5-trisphosphate
(Ins-1,4,5-P3) due to hydrolysis of phosphatidyl- inositol-4,5-bisphosphate
(Wahl, M., Sweatt, J. D., and Carpenter, G. (1987) Biochem. Biophys. Res.
Commun. 142, 688-695). The level of inositol 1,3,4,5-tetrakisphosphate
(Ins-1,3,4,5-P4) also rises rapidly in response to treatment with EGF. The
initial formation (less than 1 min) of Ins-1,4,5-P3 and Ins-1,3,4,5-P4 does
not require Ca2+ present in the culture medium. However, the addition of
Ca2+ to the medium at levels of 100 microM or greater potentiates the
growth factor- stimulated increases in the levels of all inositol
phosphates at later times after EGF addition (1-60 min). The data suggest
that EGF-receptor complexes initially stimulate the enzyme phospholipase C
in a manner that is independent of an influx of extracellular Ca2+. The
presence of Ca2+ in the medium allows prolonged growth factor activation of
phospholipase C. Treatment of A-431 cells with Ca2+ ionophores (A23187 and
ionomycin) did not mimic the activity of EGF in producing a rapid increase
in the formation of the Dowex column fraction containing Ins- 1,4,5-P3,
Ins-1,3,4,5-P4, and inositol 1,3,4-trisphosphate (InsP3). However, the
initial EGF-stimulated formation of inositol phosphates was substantially
diminished in cells loaded with the Ca2+ chelator Quin 2/AM. EGF receptor
occupancy studies indicated that maximal stimulation of InsP3 accumulation
by EGF requires nearly full (75%) occupancy of available EGF binding sites,
while half-maximal stimulation requires 25% occupancy.
12-O-Tetradecanoylphorbol-13- acetate (TPA), an exogenous activator of
Ca2+/phospholipid-dependent protein kinase (protein kinase C), causes a
dramatic, but transient, inhibition of the EGF-stimulated formation of
inositol phosphates. Tamoxifen and sphingosine, reported pharmacologic
inhibitors of protein kinase C activity, potentiate the capacity of EGF to
induce formation of inositol phosphates. Neither TPA nor tamoxifen
significantly affects the 125I-EGF binding capacity of A-431 cells;
however, TPA appeared to enhance internalization of the ligand. Ligand
occupation of the EGF receptor on the A-431 cell appears to initiate a
complex signaling mechanism involving production of intracellular
messengers for Ca2+ mobilization and activation of protein kinase
C.(ABSTRACT TRUNCATED AT 400 WORDS)

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Sekiya, B. Poulin, Y. J. Kim, and S. G. Rhee
Mechanism of Tyrosine Phosphorylation and Activation of Phospholipase C-{gamma}1: TYROSINE 783 PHOSPHORYLATION IS NOT SUFFICIENT FOR LIPASE ACTIVATION
J. Biol. Chem.,
July 30, 2004;
279(31):
32181 - 32190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-P. Li, L. Tsiokas, S. C. Sansom, and R. Ma
Epidermal Growth Factor Activates Store-operated Ca2+ Channels through an Inositol 1,4,5-Trisphosphate-independent Pathway in Human Glomerular Mesangial Cells
J. Biol. Chem.,
February 6, 2004;
279(6):
4570 - 4577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-J. Yeo and J. H. Exton
Stimulation of Phospholipase D by Epidermal Growth Factor Requires Protein Kinase C Activation in Swiss 3T3 Cells
J. Biol. Chem.,
February 24, 1995;
270(8):
3980 - 3988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Todderud, M. Wahl, S. Rhee, and G Carpenter
Stimulation of phospholipase C-gamma 1 membrane association by epidermal growth factor
Science,
July 20, 1990;
249(4966):
296 - 298.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wahl, T. Daniel, and G Carpenter
Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells
Science,
August 19, 1988;
241(4868):
968 - 970.
[Abstract]
[PDF]
|
 |
|
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|